Pharmacokinetics of cefotetan (YM09330) in humans.
The pharmacokinetics and safety of cefotetan (YM09330) were examined after intravenous administration of single and multiple doses to normal volunteers. Cefotetan was well tolerated in single doses of 500 to 3,000 mg and in multiple doses of 500 and 1,000 mg at 12-h intervals for 1 and 3 days. These...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1982
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185696/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6961888/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.22.6.935 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|